{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:11:14Z","timestamp":1778217074596,"version":"3.51.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Male breast cancer (MBC) is a rare malignancy, accounting for about 1% of all breast cancers. Treatment guidelines are largely extrapolated from female breast cancer (FBC) studies, with limited MBC\u2212specific evidence. This study evaluates the impact of postmastectomy radiotherapy (PMRT) on survival outcomes in MBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using the SEER database (2004\u20132015) and the Shanghai Jiao Tong University Breast Cancer Data Base (SJTUBCDB). Included were MBC patients with T1\u20132N1M0 disease after mastectomy. Inverse probability of treatment weighting (IPTW) was used to balance baseline characteristics. Overall survival (OS), breast cancer\u2212specific survival (BCSS), and disease\u2212free survival (DFS) were compared between PMRT and non\u2212PMRT groups. Competing risks were accounted for in BCSS analysis using the Fine-Gray subdistribution hazard model. Subgroup analyses were based on tumor size, lymph node involvement, and hormone receptor status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 714 eligible SEER patients, 33.9% received PMRT. PMRT was associated with improved OS (HR 0.79, 95% CI 0.53\u20130.94), especially in patients with T2 tumors, 2\u20133 positive lymph nodes, or negative progesterone receptor (PR) status. Competing risk analysis confirmed no significant difference in BCSS (subdistribution HR 0.79, 95% CI 0.44\u20131.42). No significant difference in BCSS was observed. In the SJTUBCDB cohort (n=50), similar directional trends were noted: PMRT was linked to better OS and DFS in high\u2212risk subgroups, particularly in Luminal B subtypes and patients with T2 tumors or multiple involved lymph nodes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PMRT was associated with improved OS in selected MBC patients with high\u2212risk features such as larger tumors or PR\u2212negative disease. The consistent findings from SEER and SJTUBCDB support the use of PMRT in high\u2212risk MBC patients and highlight the need for personalized treatment strategies and prospective trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1801550","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:47:43Z","timestamp":1778215663000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of postmastectomy radiotherapy in male breast cancer: a multicenter retrospective study"],"prefix":"10.3389","volume":"16","author":[{"given":"Xi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Oncological Surgery, Shaoxing Second Hospital","place":["Shaoxing, Zhejiang, China"]},{"name":"Department of Clinical Medicine, Shaoxing University School of Medicine","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingli","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Early Childhood Education, Shaoxing Vocational & Technical College","place":["Shaoxing, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongjie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Sanming First Hospital Affiliated to Fujian Medical University","place":["Sanming, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YongTian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Sanming First Hospital Affiliated to Fujian Medical University","place":["Sanming, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21754","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5152\/tjbh.2015.2711","article-title":"Male breast cancer","volume":"12","author":"Yalaza","year":"2016","journal-title":"J Breast Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/clep.s428824","article-title":"Time trends in male breast cancer incidence, mortality, and survival in Austria (1983\u20132017)","volume":"16","author":"Ilic","year":"2024","journal-title":"Clin Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.01.009","article-title":"Incidence of male breast cancer in Scotland over a twenty-five-year period (1992\u20132017)","volume":"46","author":"Reddington","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky018","article-title":"Exclusion of male patients in breast cancer clinical trials","volume":"2","author":"Duma","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/b:brea.0000010701.08825.2d","article-title":"Is male breast cancer similar or different than female breast cancer","volume":"83","author":"Anderson","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx651","article-title":"Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00129-018-4267-8","article-title":"Interdisziplin\u00e4re S3-Leitlinie \u201cFr\u00fcherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms \u201c","volume":"51","author":"W\u00f6ckel","year":"2018","journal-title":"Die Gyn\u00e4kologie"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.02.007","article-title":"Postmastectomy radiation therapy is associated with improved survival in node-positive male breast cancer: a population analysis","volume":"98","author":"Abrams","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100359","article-title":"The use of adjuvant radiation therapy in male breast cancer and its impact on outcomes","volume":"27","author":"Bakalov","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/cncr.32472","article-title":"Male breast cancer in the United States: treatment patterns and prognostic factors in the 21st century","volume":"126","author":"Yadav","year":"2020","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/coc.0000000000000078","article-title":"Radiotherapy and male breast cancer: a population-based registry analysis","volume":"39","author":"Madden","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000354122","article-title":"Male breast cancer: 20-year survival data for post-mastectomy radiotherapy","volume":"8","author":"Eggemann","year":"2013","journal-title":"Breast Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-5-512","article-title":"Sentinel lymph node biopsy in male patients with early breast cancer","volume":"12","author":"Gentilini","year":"2007","journal-title":"Oncologist"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2015.0876","article-title":"Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study","volume":"150","author":"Sagara","year":"2015","journal-title":"JAMA Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.65.1869","article-title":"Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based longitudinal cohort study","volume":"34","author":"Sagara","year":"2016","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq198","article-title":"Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2014a simulation study","volume":"172","author":"Sturmer","year":"2010","journal-title":"Am J Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3747\/co.25.3729","article-title":"Clinical practice guidelines in breast cancer","volume":"25","author":"Tyagi","year":"2018","journal-title":"Curr Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-018-4921-9","article-title":"Male breast cancer: a disease distinct from female breast cancer","volume":"173","author":"Gucalp","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3109\/0284186x.2011.602114","article-title":"Similarities and differences in the characteristics and primary treatment of breast cancer in men and women\u2013a population based study (Sweden)","volume":"50","author":"Nilsson","year":"2011","journal-title":"Acta Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.25.5729","article-title":"Multidisciplinary meeting on male breast cancer: summary and research recommendations","volume":"28","author":"Korde","year":"2010","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000110025","article-title":"Male and female breast cancer\u2013differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis","volume":"74","author":"Andr\u00e9","year":"2007","journal-title":"Pathobiology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.02.017","article-title":"Male breast cancer is not congruent with the female disease","volume":"101","author":"Fentiman","year":"2016","journal-title":"Crit Rev Oncology\/Hematology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/jop.19.00792","article-title":"Management of male breast cancer: ASCO guideline","volume":"38","author":"Hassett","year":"2020","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/cco.0000000000000678","article-title":"Adjuvant treatment of early male breast cancer","volume":"32","author":"Corti","year":"2020","journal-title":"Curr Opin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.23.8162","article-title":"Male breast cancer: a population-based comparison with female breast cancer","volume":"28","author":"Anderson","year":"2010","journal-title":"J Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22589","article-title":"Male breast cancer in the veterans affairs population: a comparative analysis","volume":"109","author":"Nahleh","year":"2007","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"key":"B29","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ijrobp.2011.01.010","article-title":"The impact of post-mastectomy radiation therapy on male breast cancer patients\u2014a case series","volume":"82","author":"Yu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s13566-012-0062-7","article-title":"A population-based study of the impact of post-mastectomy radiation on survival for male breast cancer","volume":"1","author":"Sroufe","year":"2012","journal-title":"J Radiat Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.01.006","article-title":"Impact of adjuvant radiation therapy in patients with male breast cancer: a multicenter international analysis","volume":"5","author":"Rolf","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.24.3.663","article-title":"Male breast cancer: a special therapeutic problem. Anything new","volume":"24","author":"Gennari","year":"2004","journal-title":"Int J Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2147\/cia.s314689","article-title":"Cardiovascular and other competing causes of death in male breast cancer patients: a population-based epidemiologic study","volume":"16","author":"Zhang","year":"2021","journal-title":"Clin Interv Aging"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1801550\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:47:48Z","timestamp":1778215668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1801550\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":33,"alternative-id":["10.3389\/fonc.2026.1801550"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1801550","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1801550"}}